
Telfirst-H Tablet
Marketer
Zyphar's Pharmaceuticals Pvt Ltd
Salt Composition
Telmisartan (40mg) + Hydrochlorothiazide (12.5mg)
Overview Telfirst-H Tablet
Combifirst-HP tablets combine two medications to manage hypertension, typically prescribed when a single medication proves insufficient. This dual-action approach reduces the risk of future strokes and heart attacks by effectively lowering blood pressure. Consumption with or without food is acceptable; dosage is personalized and should be taken consistently at the same time daily. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. The formulation includes a diuretic, increasing urination; therefore, avoid doses within four hours of bedtime. Consistent use, even feeling well, is vital for optimal therapeutic benefit. Hypertension often presents without symptoms. Common side effects may include dizziness, fatigue, nausea, dyspnea, and palpitations; however, increased urination is an intended therapeutic effect, not a side effect. While other less frequent side effects are possible, always consult the accompanying patient information leaflet and report persistent or bothersome side effects to your doctor, who may adjust the dosage or medication. Avoid potassium supplements or salt substitutes unless explicitly instructed by your doctor. Consult your doctor before use if pregnant, breastfeeding, or with kidney, liver, or heart disease, or diabetes. Alcohol consumption may exacerbate blood pressure reduction and side effects.
Primary Ingredients of Telfirst-H Tablet
There is no text provided to rephrase.
Uses of Telfirst-H Tablet
Managing Elevated Blood Pressure
Major Benefits of Telfirst-H Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Telfirst-H Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Telfirst-H Tablet:
- Fatigue
- Dizziness
- Nausea
- Decreased magnesium level in blood
How to use Telfirst-H Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Telfirst-H Tablets can be ingested with or without food, however, consistent timing is recommended.
How Telfirst-H Tablet works:
Telfirst-H Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Telfirst-H Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Telfirst-H Tablets during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Employing Telfirst-H tablets while breastfeeding presents a likely risk. Available human data, though scant, indicate potential drug transfer to breast milk, posing a possible threat to the infant.
DrivingUNSAFE
Taking Telfirst-H Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving while experiencing these effects is strongly discouraged.
KidneyCAUTION
Patients with severely impaired kidney function should exercise caution when using Telfirst-H Tablets, potentially requiring dosage modification. Physician consultation is advised. Telfirst-H Tablets are contraindicated in patients with severe renal disease.
LiverCAUTION
Patients with liver impairment should use Telfirst-H Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telfirst-H Tablet :
Should you forget a Telfirst-H Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telfirst-H Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
